Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

The deal with Lonza will close. Gerald stated on the call yesterday that most of the monthly payments are going toward preparing ESS for the Phase 2 trial.

ESS is worth big money and closing on that deal as it is ready to begin the Phase 2 trial will be huge. They also talked about grant money this is available on closing the deal and additional grant money they will pursue after closing the deal.

This could be huge for AMBS. IMO